Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

BR Haight, SM Learned, CM Laffont, PJ Fudala, Y Zhao… - The Lancet, 2019 - thelancet.com
Background RBP-6000, referred to as BUP-XR (extended-release buprenorphine), is a
subcutaneously injected, monthly buprenorphine treatment for opioid use disorder. BUP-XR …

[HTML][HTML] Sodium zirconium cyclosilicate in hyperkalemia

DK Packham, HS Rasmussen, PT Lavin… - … England Journal of …, 2015 - Mass Medical Soc
Background Hyperkalemia (serum potassium level,> 5.0 mmol per liter) is associated with
increased mortality among patients with heart failure, chronic kidney disease, or diabetes …

Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non …

KM Dungan, ST Povedano, T Forst, JGG González… - The Lancet, 2014 - thelancet.com
Background Dulaglutide and liraglutide, both glucagon-like peptide-1 (GLP-1) receptor
agonists, improve glycaemic control and reduce weight in patients with type 2 diabetes. In a …

Gatekeeping procedures with clinical trial applications

A Dmitrienko, AC Tamhane - … Journal of Applied Statistics in the …, 2007 - Wiley Online Library
The objective of this paper is to give an overview of a relatively new area of multiplicity
research that deals with the analysis of hierarchically ordered multiple objectives. Testing …

[图书][B] Multiple testing problems in pharmaceutical statistics

A Dmitrienko, AC Tamhane, F Bretz - 2009 - books.google.com
Bringing together leading statisticians, scientists, and clinicians from the pharmaceutical
industry, academia, and regulatory agencies, this volume explores the rapidly growing area …

Opportunities and challenges of combined effect measures based on prioritized outcomes

G Rauch, A Jahn‐Eimermacher… - Statistics in …, 2014 - Wiley Online Library
Many authors have proposed different approaches to combine multiple endpoints in a
univariate outcome measure in the literature. In case of binary or time‐to‐event variables …

Tamoxifen pharmacogenetics and metabolism: results from the prospective CYPTAM study

A Sanchez-Spitman, V Dezentjé, J Swen… - Journal of Clinical …, 2019 - ascopubs.org
PURPOSE Tamoxifen is widely prescribed as adjuvant therapy in patients with early-stage
breast cancer. It has been postulated that concentrations of endoxifen, the active metabolite …

Oxybutynin vs placebo for hot flashes in women with or without breast cancer: a randomized, double-blind clinical trial (ACCRU SC-1603)

RA Leon-Ferre, PJ Novotny, EG Wolfe… - JNCI Cancer …, 2020 - academic.oup.com
Abstract Background Hot flashes (HFs) negatively affect quality of life among
perimenopausal and postmenopausal women. This study investigated the efficacy of …

[图书][B] Bioequivalence and statistics in clinical pharmacology

SD Patterson, B Jones - 2017 - taylorfrancis.com
Maintaining a practical perspective, Bioequivalence and Statistics in Clinical Pharmacology,
Second Edition explores statistics used in day-to-day clinical pharmacology work. The book …

[HTML][HTML] The effects of tai chi and neck exercises in the treatment of chronic nonspecific neck pain: a randomized controlled trial

R Lauche, C Stumpe, J Fehr, H Cramer, YW Cheng… - The Journal of …, 2016 - Elsevier
This study aimed to test the efficacy of Tai Chi for treating chronic neck pain. Subjects with
chronic nonspecific neck pain were randomly assigned to 12 weeks of group Tai Chi or …